About Zoetis Inc. Class A Common Stock
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
2BB score and signals
Zoetis Inc. Class A Common Stock’s current 2BB score is 54 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 53 | Moderate |
| Momentum | 48 | Stable |
| Financial strength | 76 | Strong |
| Quality | 97 | Very Strong |
| Risk | 26 | Low |
Company facts
| CEO | Kristin C. Peck |
| Headquarters | Parsippany-Troy Hills, New Jersey, United States |
| Founded | 1952 |
| Employees | 14.5K |
| P/E ratio | 12.39 |
| 52-week range | $68.77 – $148.30 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-10 | — | 1.3042 | — | $2.25B |
| 2026-11-05 | — | 1.5291 | — | $2.32B |
| 2026-08-06 | — | 1.8742 | — | $2.53B |
| 2026-05-07 | 1.53 | 1.6309 | $2.26B | $2.33B |
Related companies
